Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Receives $33.90 Average Target Price from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) saw a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 6,020,000 shares, an increase of 10.7% from the August 31st total of 5,440,000 shares. Based on an average daily volume of 659,700 shares, the short-interest […]
Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) reached a new 52-week low during trading on Thursday . The company traded as low as $20.48 and last traded at $20.68, with a volume of 441458 shares. The stock had previously closed at $20.80. Wall Street Analysts Forecast Growth CERE has been the […]